You are on page 1of 2

100 Years of Insulin:

LEGACY OF LIFE CHANGING INNOVATION


Novotel Bangka Hotel and Convention Centre
22-23 Oct 2022

1st Day - Saturday, 22 October 2022


TIME TOPIC SPEAKER
13.00-13.10 WIB • Opening by MC • MC: Mecca Medina & Haris Budiman
• Speech by Sanofi Indonesia • Hector Reyes – General Menager
• Opening Speech by PP PERKENI GENMED Sanofi Indonesia
• Prof.Dr.dr. K. Suastika, SpPD-KEMD
– Head of PP PERKENI

IDLS 2022 HIGLIGHT


Moderator: Dr. dr. Wismandari, Sp.PD-KEMD

13.10 – 14.00 ADA & EASD Highlights 2022 and


WIB clinical implication in real practices;
1. Diabetes Care and Education 1. Prof. Dr. dr. Pradana Soewondo,
Specialists Diabetes educator Sp.PD-KEMD
Value – Positive Impact of
Diabetes Educator on Therapeutic 2. Dr. Mardianto, Sp.PD-KEMD
Inertia
2. The latest data from the InRange 3. Prof. Dr.dr. K. Suastika, SpPD-
study and the ULTRAFLEXI-1 KEMD
trial
3. The importance of addressing 4. dr. Hendra Zufry, Sp.PD-KEMD
both fasting and post-prandial
4. Sub-analyses from the SoliMix
trial: iGlarLixi as a more effective
alternative to complex insulin
regimens like premix.

TALK SHOW-1
Moderator: Dr. dr. Jazil Karimi, SpPD-KEMD

14.05-14.30 WIB Insulin usage in Special condition; Dr. dr. Yuanita Langi, SpPD-KEMD
Pregnancy & CKD

TALK SHOW-2
Moderator: dr. R. Bowo Pramono, SpPD-KEMD

14.35 -15.00 WIB Physician led titration vs patient led 1. Prof. Dr. dr. Andi Makbul Aman,
titration with Insulin therapy; Which SpPD-KEMD
one better? 2. Dr. dr. Hikmat Permana, SpPD-
KEMD

Sanofi Indonesia - PT Aventis Pharma


Jalan Jend. Ahmad Yani No.2 Pulomas, Kayu Putih, Pulogadung, Jakarta 13210 Indonesia - Telp. +62 (21) 4892208 – 4895608 - Fax. +62 (21) 4751035 - www.sanofi.co.id

PA
Sanofi Indonesia - PT Aventis Pharma
TIME TOPIC SPEAKER
TALK SHOW-3
Moderator: Dr. dr. Em Yunir, Sp.PD-KEMD

15.05 - 15.30 WIB Pro & Cons: Sulfonylurea vs • dr. Tania Tedjo Minuljo, SpPD-
newer generation OAD KEMD
• dr. M. Ikhsan Mokoagow,
M.Med.Sci., SpPD-KEMD

CASE BASED SERIES


Moderator: Dr. dr. I Made Pande Dwipayana, SpPD-KEMD

15.35-16.30 WIB 1. Hyperglycemia in Critically ill in 1. Dr. dr. R. Dyah Purnamasari,


T2DM SpPD-KEMD
2. Outpatient setting with FRC 2. Dr. dr. K. Heri Nugroho H.S, SpPD-
Regiment KEMD
3. Non Critically ill with U300 in 3. Dr. dr Himawan Sanusi, Sp.PD-
T2DM KEMD

16.35 – 16.40 WIB 1st day Closing Remark by Sanofi Benyamin Wuisan – Head of Diabetes
Indonesia Business Unit Sanofi Indonesia

16.40 WIB Information Remark by MC

2nd Day - Sunday, 23 October 2022


TIME TOPIC SPEAKER
08.00 – 08.10 WIB Opening by MC MC: Mecca Medina & Haris Budiman

TALK SHOW:
Moderator: dr. Ratna Maila Dewi, SpPD-KEMD

08.10 – 09.30 WIB Coming together for Diabetes Care • Dr. dr. Tri Juli Edi Tarigan, SpPD-
& Patients Safety through KEMD
INCONTROL Program • Dr. dr. Fatimah Eliana, SpPD-
KEMD
• Dr. dr. Santi Syafril, SpPD-KEMD

09.30 WIB Closing Remark by PP PERKENI Prof.Dr.dr. K. Suastika, SpPD-KEMD


– Head of PP PERKENI
Closing IDLS 2022 by MC

Sanofi Indonesia - PT Aventis Pharma


Jalan Jend. Ahmad Yani No.2 Pulomas, Kayu Putih, Pulogadung, Jakarta 13210 Indonesia - Telp. +62 (21) 4892208 – 4895608 - Fax. +62 (21) 4751035 - www.sanofi.co.id
Page: 2/2

You might also like